Omvoh is used to treat moderately to severely active ulcerative colitis or Crohn's disease in adults. It can be self-administered by injection under the skin (subcutaneously) every 4 weeks after an initial IV infusion by a healthcare provider.

Omvoh is a prescription medicine used to treat adults with moderate to severe ulcerative colitis and adults with moderate to severe Crohn's disease. Biologic medicines are usually given by intravenous (IV) infusion or subcutaneous injection. Biologic medicines are proteins that would break down in stomach acid.

Apr 24, 2024 · Omvoh (mirikizumab-mrkz) is a prescription drug that’s used to treat ulcerative colitis in adults. Omvoh comes as a liquid solution that’s given as an injection under your skin or as an...

Jan 13, 2025 · Omvoh (mirikizumab-mrkz) is commonly used to treat the following conditions. Learn more about Omvoh for ulcerative colitis. Omvoh may also be used for other conditions as determined by your...

Feb 13, 2024 · Omvoh is a brand-name injectable drug that’s prescribed for ulcerative colitis. Omvoh contains the active ingredient mirikizumab-mrkz and is a type of monoclonal antibody.

Jan 22, 2025 · Omvoh (mirikizumab-mrkz) is an interleukin-23 antagonist indicated for the treatment of moderately to severely active ulcerative colitis in adults. What Are Side Effects of Omvoh? Side effects of Omvoh include: herpes viral infection. Seek medical care or call 911 at once if you have the following serious side effects:

Omvoh injection is available as a 300mg/15 mL solution in a single-dose vial for intravenous infusion, and as a 100 mg/mL solution or a 200 mg/2 mL solution in a single dose prefilled pen or prefilled syringe for subcutaneous injection. Refer to the Prescribing Information for dosing information. MR HCP ISI CD APP.

OMVOH TM is an interleukin-23 antagonist indicated for the treatment of: Prior to Treatment Initiation. Important Administration Instructions. Recommended Dosage for Ulcerative Colitis. Recommended Dosage for Crohn's Disease. Preparation and Administration Instructions. Intravenous Infusion (3) Subcutaneous Injection (3):

Mirikizumab, sold under the brand name Omvoh, is a monoclonal antibody used for the treatment of ulcerative colitis. [5] . It is designed to attach to interleukin-23 (IL-23) and block its activity. [5]

Jun 13, 2024 · Learn about the side effects of Omvoh (mirikizumab), from common to rare, for consumers and healthcare professionals.